Paper Type |
:: |
Research Paper |
Title |
:: |
Development and Validation of RP-HPLC Method For quantitative Estimation of Cetirizine HCL in Pharmaceutical Formulation as Per ICH Guideline |
Country |
:: |
India |
Authors |
:: |
Dr. Gayatri Barabde, AartiBabu Kokate, Dr. Sushama Ambadekar |
Page No. |
:: |
01-09 |
Background: A simple, specific, linear, precise and accurate reverse phase liquid chromatographic (RP-HPLC) method was developed to analysis speed by minimizing run time and retention timeof Cetirizine Hydrochloride in tablet dosage forms. The chromatographic separation was performed using Phenomenex Luna 5μ C18 100A (250 x 4.6 mm). Mobile phase composed of Acetonitrile and water (60:40 v/v) was selected and a flow rate of 1.000 ml/minute is monitored..........
Keywords : Cetirizine Hydrochloride, method development, Validation
[1].
Rudaz. S., Souverain. S., Schelling. C.,andDeleersM.Anal. Chim. Acta,Development and validation of a heart-cutting liquid chromatography–mass spectrometry method for the determination of process-related substances in cetirizine tablets.2003, 492:271–282.
[2].
Nightingale, C.H. 1996. Treating allergic rhinitis with second-generation antihistamines. Pharmacotherapy, 1996, 16: 904-914.
[3].
P Beringer, A der Marderosian, L. Felton, et al, "Remington: The Science and Practice of Pharmacy" Lippincott Williams & Wilkins, Philadelphia, 21st ed., 2006.
[4].
European Medicines Agency, "Guideline on Excipients in the Dossier for Application for Marketing Authorisation of a Medicinal Product" Doc. Ref. EMEA/CHMP/QWP/396951 /2006, London, 6 November 2006.
[5].
Kuchekar BS, Shinde GS, Naikwadi IT, Todkar KJ, Kharade SV, "Specrtophotometric estimation of ambroxol hydrochloride in tablets" Indian J Pharm Sci, 2003; 65(2): 193-195.
Paper Type |
:: |
Research Paper |
Title |
:: |
Study of Core Shell n-Octyl Cinnamate in Nano Particle as Anti-Inflamatories |
Country |
:: |
|
Authors |
:: |
AchmadWildan, ErlitaVerdia Mutiara, Erwin Indriyanti, Mighfar Syukur |
Page No. |
:: |
10-16 |
N-octyl cinnamic is a compound that has potential as a drug as an antioxidant, anti-inflammatory, but is constrained by the nature of n-octyl cinnamate which is difficult to dissolve in water, causing low bioavailability in the systemic circulation. To overcome this problem, curcumin is formulated in the form of nanoparticles using chitosan polymer, a derivative of chitin which can be obtained from crab and shrimp shell waste. This study aims to synthesize n-octyl cinnamic nanoparticles using a simple.......
Keywords:Nanoparticle, Anti-inflammatory, n-octyl cyanamate/Alginate/chitosan, Synthesis
[1] J. D. Guzman, "Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity,"
Molecules, vol. 19, no. 12. MDPI AG, pp. 19292–19349, Dec. 2014, doi: 10.3390/molecules191219292.
[2] T. Vogt, "Phenylpropanoid biosynthesis," Mol. Plant, vol. 3, no. 1, pp. 2–20, 2010, doi:
10.1093/mp/ssp106.
[3] S. B. França, P. R. dos S. Correia, I. B. D. de Castro, E. F. da Silva Júnior, M. E. de S. B. Barros, and D.
J. da P. Lima, "Synthesis, applications and Structure-Activity Relationship (SAR) of cinnamic acid
derivatives: a review," Res. Soc. Dev., vol. 10, no. 1, p. e28010111691, 2021, doi: 10.33448/rsdv10i1.11691
Paper Type |
:: |
Research Paper |
Title |
:: |
Prevalence and Risk Factors Associated with Type 2 Diabetes in Elderly Patients |
Country |
:: |
|
Authors |
:: |
xxx |
Page No. |
:: |
17-20 |
Diabetes mellitus (DM), also termed as "sugar," is a chronic, noncommunicable disease (NCD) which has emerged as one of the leading global health problem associated with the pancreas in the production of insulin leading to hyperglycemia . Type 2 diabetes mellitus is associated with a combination of resistance to insulin action and inadequate.....
[1].
C. Bommer, V. Sagalova, E. Heesemann et al., "Global economic burden of diabetes in adults: projections from 2015
[2].
to 2030," Diabetes Care, vol. 41, no. 5, pp. 963–970, 2018.View at: Publisher Site | Google Scholar
[3].
F. S. Chiwanga, M. A. Njelekela, M. B. Diamond et al., "Urban and rural prevalence of diabetes and pre-diabetes and
[4].
risk factors associated with diabetes in Tanzania and Uganda," Global Health Action, vol. 9, no. 1, article 31440, 2016.View at: Publisher Site | Google Scholar
[5].
R. Dehnavieh, A. Haghdoost, A. Khosravi et al., "The District Health Information System (DHIS2): A literature review.
Paper Type |
:: |
Research Paper |
Title |
:: |
Anti-gastric ulcer activity of PerichlaenarichardiiBaill (Bignoniaceae) in rat |
Country |
:: |
|
Authors |
:: |
Solofoniaina Gabriel ANDRIAMALALA,TianarilalainaTantely ANDRIAMAMPIANINA, Nathaniel QUANSAH, Fanantenanirainy RANDIMBIVOLOLONA,Patricia RANDRIANAVONY |
Page No. |
:: |
21-25 |
This work aimed to investigate the anti-gastric ulcer activity of the hydro alcoholic extract of Perichlaenarichardii leaves in rat. Its effect on gastric mucosa was studied on gastric lesions induced by orally administering indomethacin at dose 30 mg/kg for 5 days. Misoprostol, at the dose of 1.4 μg/kg, was used as reference, while the effect of extract P. richardii on acid secretion was investigated after pylorus ligation. The extract P. richardii reduces indomethacin induced gastric surface ulcerous lesions. The administration of the extract at doses 150 and.......
Keywords: anti-secretory,antiulcer, muco-protector, rat
[1]
A. Allen, G. Flemstrom, A. Garner, and E. Kivilaakso,Gastroduodenal mucosal protection,American Physiological Society, 73(4), 1993, 823-830.
[2]
A. Allen and G.Flemström, Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin,American Journal of Physiology, 288(1), 2005, C1-9.
[3]
JD. Kaunitz andY.Akiba, Gastroduodenal mucosal defense: Role of endogenous mediators. Current Opinion in Gastroenterology, 20, 2004, 526-532.
[4]
R. Gadekar, PK. Singour, PK. Chaurasiya, RS. Pawar andUK. Patil, A potential of some medicinal plants as an antiulcer agents,Pharmacognosy Reviews, 4(8), 2010, 136.
[5]
HHS.Fong, Tin-Win and NR. Farnsworth. Phytochemical Screening plants,Pharmacological Reviews, University of Illinois, Chicago (USA), 1977, 275-277-
Paper Type |
:: |
Research Paper |
Title |
:: |
Physicochemical Characterization and Dissolution Studies of Ketoprofen Solid Dispersions with Cationic Polymers |
Country |
:: |
Saudi Arabia |
Authors |
:: |
Rehab Mohammad Yusif |
Page No. |
:: |
26-34 |
Background: Ketoprofen (KETO) is an example of drugs with limited solubility and high permeability that are classified as biopharmaceutics classification system (BCS) class II. Its poor water solubility can give rise to formulation problems and reduce its therapeutic efficiency and bioavailability. Materials and Methods: A simple solution mixing method was used to formulate KETO into solid dispersion with cationic hydrophilic polymers; Eudragit® E (EE) and chitosan (CH). These solid dispersions were prepared at various drug.....
Key-words: Ketoprofen; Chitosan; Eudragit E; Solid dispersion; Solvent evaporation
[1].
Adeyeye MC, Brittain HG (Eds.) Preformulation solid dosage form development; Informa Healthcare USA: New York, NY, USA, 2008.
[2].
Di L, Fish PV, Mano T, Bridging solubility between drug discovery and development. Drug Discov Today. 2012; 17(9-10): 486–495.
[3].
Kalepu S, Nekkanti V, Insoluble drug delivery strategies: Review of recent advances and business prospects. Acta Pharm. Sin. B. 2015; 5: 442–453.
[4].
Tsume Y, Langguth P, Garcia-Arieta A, Amidon GL, In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: Ibuprofen and ketoprofen. Biopharm. Drug Dispos. 2012; 33: 366–377.
[5].
Maestrelli F, Zerroukb N, Cirri M, Menninia N, Mura P, Microspheres for colonic delivery of ketoprofen-hydroxypropyl-β-cyclodextrin complex. Eur. J. Pharm. Sci. 2008; 34: 1-11..
Paper Type |
:: |
Research Paper |
Title |
:: |
Chemical Stability of Compounded Atorvastatin Suspension Over a 5-week Period at Varied Temperature and Storage Conditions |
Country |
:: |
USA |
Authors |
:: |
Jace Swingle, Madison Grilliot, Julie Oestreich, Richard Dudley |
Page No. |
:: |
35-40 |
Background: Atorvastatin, an inhibitor of 3-hydroxy-3-methylglutarylcoenzyme-A (HMG-CoA) reductase, is widely prescribed in adult and pediatric patients for its potent cholesterol lowering effect. However, atorvastatin is only commercially available in tablet form. Therefore, pharmacists have compounded atorvastatin suspension making the medication available to more pediatric patients and select adults unable to take tablets. Limited reports on the preparation.....
Key-words: Stability; Chemical stability; HPLC; Suspension; Physicochemical properties; US Pharmacopeia (USP)
[1]. Lexicomp Online L-DO: Wolters Kluwer Health, Inc. Atorvastatin 2021. Available at: http://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/6396?cesid=5X8q1ar9aaE&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Datrovastatin%26t%3Dname%26va%3Datrovastatin. Accessed February 15, 2021.
[2]. Rollins DE, Blumenthal DK. Drug Therapy of Dyslipidemias. Workbook and Casebook for Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill Education; 2016:948-53.
[3]. Zaid AN, Assali M, Zalmout S, Basheer A. Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder. Eur J Hosp Pharm. 2017;24(3):157-61.
[4]. Goel A, Baboota S, Sahni JK, Srinivas KS, Gupta RS, Gupta A, et al. Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe. J Chromatogr Sci. 2013;51(3):222-8.
[5]. Oliveira MA, Yoshida MI, Belinelo VJ, Valotto RS. Degradation kinetics of atorvastatin under stress conditions and chemical analysis by HPLC. Molecules. 2013;18(2):1447-56...
©All Rights Reserved | Design by iosrphr